| Clinical data | |
|---|---|
| Other names | LY-79907; 2-Chloro-6-methylergoline-8β-acetonitrile |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H18ClN3 |
| Molar mass | 299.80 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Lergotrile (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name; developmental code nameLY-79907) is anergolinederivative which acts as adopamine receptor agonist. It was developed for the treatment ofParkinson's disease, but failed inclinical trials due toliver toxicity.[1][2]
The drug'shydroxylatedmetabolite13-hydroxylergotrile is 100-fold morepotent as a dopamine receptor agonist than lergotrile itselfin vitro.[3][4]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byadding missing information. |